{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:04:06Z","timestamp":1780373046913,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,19]],"date-time":"2016-09-19T00:00:00Z","timestamp":1474243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"BBSRC\/GSK (UK) CASE award (NL)"},{"DOI":"10.13039\/501100000304","name":"Parkinson\u2019s UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000304","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.phrs.2016.08.034","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T15:00:51Z","timestamp":1473260451000},"page":"245-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"PA","title":["Ligand autoradiographical quantification of histamine H 3 receptor in human dementia with Lewy bodies"],"prefix":"10.1016","volume":"113","author":[{"given":"Natasha L.","family":"Lethbridge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Chazot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2016.08.034_bib0005","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1212\/WNL.47.5.1113","article-title":"Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy-body (DLB): report on the consortium on DLB international workshop","volume":"47","author":"McKeith","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2016.08.034_bib0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1124\/mi.6.2.5","article-title":"Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders","volume":"6","author":"Esbenshade","year":"2006","journal-title":"Mol. Interv."},{"key":"10.1016\/j.phrs.2016.08.034_bib0015","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.bcp.2006.10.031","article-title":"Histamine H3 receptor antagonists: from target identification to drug leads","volume":"73","author":"Bonaventure","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2016.08.034_bib0020","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/bjp.2008.147","article-title":"The histamine H3 receptor: an attractive target for the treatment of cognitive disorders","volume":"154","author":"Esbenshade","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2016.08.034_bib0025","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1124\/pr.114.010249","volume":"67","author":"Panula","year":"2015","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2016.08.034_bib0030","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1124\/jpet.107.120311","article-title":"GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer\u2019s disease brain and improves cognitive performance in preclinical models","volume":"321","author":"Medhurst","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.08.034_bib0035","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.bcp.2007.01.007","article-title":"Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats","volume":"73","author":"Medhurst","year":"2007","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2016.08.034_bib0040","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1021\/jm040118g","article-title":"4-(2-[2-(2(R)-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and related 2-aminoethylbenzofuran H3 receptor antagonists potently enhance cognition and attention","volume":"48","author":"Cowart","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2016.08.034_bib0045","first-page":"353","article-title":"Brain histamine in Alzheimer\u2019s disease","volume":"11","author":"Cacabelos","year":"1989","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2016.08.034_bib0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1139\/y89-013","article-title":"Changes in the regional brain histamine and histidine levels in postmortem brains of Alzheimer patients","volume":"67","author":"Mazurkiewicz-Kwilecki","year":"1989","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.phrs.2016.08.034_bib0055","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0306-4522(97)00353-9","article-title":"Neuronal histamine deficit in Alzheimer\u2019s disease","volume":"82","author":"Panula","year":"1998","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"10.1016\/j.phrs.2016.08.034_bib0060","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/BF01993139","article-title":"Neurofibrillary tangles and histamine-containing neurons in Alzheimer hypothalamus","volume":"33","author":"Airaksinen","year":"1991","journal-title":"Agents Actions"},{"key":"10.1016\/j.phrs.2016.08.034_bib0065","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0304-3940(93)90019-H","article-title":"Loss of large neurons and occurrence of neurofibrillary tangles in the tuberomammilary nucleus of patients with Alzheimer\u2019s disease","volume":"151","author":"Nakamura","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2016.08.034_bib0070","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological staging of Alzheimer\u2019s related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol. (Berl.)"},{"issue":"3","key":"10.1016\/j.phrs.2016.08.034_bib0075","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0304-3940(97)13379-1","article-title":"Similar deficits of central histaminergic system in patients with Down syndrome and Alzheimer disease","volume":"222","author":"Schneider","year":"1997","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.phrs.2016.08.034_bib0080","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1476-5381.2008.00075.x","article-title":"Characterization of histamine H3 receptors in Alzheimer\u2019s disease brain and amyloid overexpressing TASTPM mice","volume":"157","author":"Medhurst","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2016.08.034_bib0085","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/schbul\/sbt240","article-title":"A randomized trial of the efficacy and safety of the H3 antagonist ABT-288 in cognitive impairment associated with schizophrenia","volume":"40","author":"Haig","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.phrs.2016.08.034_bib0090","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1476-5381.2011.01286.x","article-title":"The histamine H3 receptor: from discovery to clinical trials with pitolisant","volume":"163","author":"Schwartz","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"April (7)","key":"10.1016\/j.phrs.2016.08.034_bib0095","article-title":"Clinical trials with H3-receptor inverse agonists: what they tell us about the role of histamine in the human brain","author":"Schwartz","year":"2016","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.phrs.2016.08.034_bib0100","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1358\/dnp.2010.23.2.1475899","article-title":"Therapeutic potential of histamine H3 receptor antagonists in dementias","volume":"23","author":"Chazot","year":"2010","journal-title":"Drug News Perspect."},{"issue":"6","key":"10.1016\/j.phrs.2016.08.034_bib0105","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0301-0082(00)00039-3","article-title":"The physiology of brain histamine","volume":"63","author":"Brown","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.phrs.2016.08.034_bib0110","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0306-4522(93)90191-H","article-title":"A detailed autoradiographic mapping of histamine H3 receptors in rat brain areas","volume":"52","author":"Pollard","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2016.08.034_bib0115","first-page":"1613","article-title":"Histamine H3 receptor antoaginst reach out for the clinical","volume":"10","author":"Leurs","year":"2005","journal-title":"Keynote Rev."},{"issue":"1","key":"10.1016\/j.phrs.2016.08.034_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-4943(91)90002-8","article-title":"Influence of age and gender on the levels of histamine metabolites and pros-methylimidazoleacetic acid in human cerebrospinal fluid","volume":"12","author":"Prell","year":"1991","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.phrs.2016.08.034_bib0125","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/j.1476-5381.1996.tb16086.x","article-title":"Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats","volume":"119","author":"Blandina","year":"1996","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2016.08.034_bib0130","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1460-9568.2002.02092.x","article-title":"Activation of histaminergic H3 receptors in the rat basolateral amygdala improves expression of fear memory and enhances acetylcholine release","volume":"16","author":"Cangioli","year":"2002","journal-title":"Eur. J. Neurosci."},{"issue":"10","key":"10.1016\/j.phrs.2016.08.034_bib0135","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1046\/j.1460-9568.2002.02005.x","article-title":"Endogenous histamine in the medial septum-diagonal band complex increases the release of acetylcholine from the hippocampus: a dual-probe microdialysis study in the freely moving rat","volume":"15","author":"Bacciottini","year":"2002","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2016.08.034_bib0140","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuropharm.2008.05.008","article-title":"Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function","volume":"55","author":"Ferrada","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.08.034_bib0145","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1006\/nbdi.2001.0413","article-title":"Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson\u2019s disease","volume":"8","author":"Anichtchik","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2016.08.034_bib0150","first-page":"299","article-title":"Demonstration of neurofibrillary tangles in paraffin sections: a quick and simple method using a modifications of Palmgren\u2019s method","volume":"39","author":"Cross","year":"1982","journal-title":"Med. Lab. Sci."},{"key":"10.1016\/j.phrs.2016.08.034_bib0155","series-title":"Theory and Practice of Histological Techniques","author":"Bancroft","year":"1990"},{"issue":"12","key":"10.1016\/j.phrs.2016.08.034_bib0160","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2016.08.034_bib0165","series-title":"Neuropsychiatric Disorders","first-page":"1.1","article-title":"A guide to the cortical regions","author":"Perry","year":"1993"},{"key":"10.1016\/j.phrs.2016.08.034_bib0170","series-title":"Atlas of the Human Brain","author":"Mai","year":"1997"},{"issue":"3","key":"10.1016\/j.phrs.2016.08.034_bib0175","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini mental state. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"issue":"5","key":"10.1016\/j.phrs.2016.08.034_bib0180","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/mds.10248","article-title":"Systematic evaluation of rating scales for impairment and disability in Parkinson\u2019s disease","volume":"7","author":"Ramaker","year":"2002","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.phrs.2016.08.034_bib0185","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1460-9568.1999.00453.x","article-title":"Distribution of histamine H3-receptor binding in the normal human basal ganglia: comparison with Huntington\u2019s and Parkinson\u2019s disease cases","volume":"11","author":"Goodchild","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.phrs.2016.08.034_bib0190","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0006-8993(90)91240-H","article-title":"Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates","volume":"526","author":"Martinez-Mir","year":"1990","journal-title":"Brain Resolut."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2016.08.034_bib0195","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jns.2011.11.013","article-title":"Preservation of cortical histamine H3 receptors in ischemic vascular and mixed dementias","volume":"315","author":"Sheng","year":"2012","journal-title":"J. Neurol. Sci."},{"issue":"11","key":"10.1016\/j.phrs.2016.08.034_bib0200","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.neurobiolaging.2011.12.026","article-title":"Alterations in the histaminergic system in Alzheimer\u2019s disease: a postmortem study","volume":"33","author":"Shan","year":"2012","journal-title":"Neurobiol. Ageing"},{"issue":"11","key":"10.1016\/j.phrs.2016.08.034_bib0205","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1046\/j.1460-9568.2000.00267.x","article-title":"Modulation of histamine H3 receptors in the brain of 6-hydroxydopamine-lesioned rats","volume":"12","author":"Anichtchik","year":"2000","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2016.08.034_bib0210","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0306-4522(00)00230-X","article-title":"Histamine H1 receptors in patients with Alzheimer\u2019s disease assessed by positron emission tomography","volume":"99","author":"Higuchi","year":"2000","journal-title":"Neuroscience"},{"issue":"4537","key":"10.1016\/j.phrs.2016.08.034_bib0215","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7058341","article-title":"Alzheimer\u2019s disease and senile dementia: loss of neurons in the basal forebrain","volume":"215","author":"Whitehouse","year":"1982","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.phrs.2016.08.034_bib0220","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tins.2014.12.008","article-title":"The human histaminergic system in neuropsychiatric disorders","volume":"38","author":"Shan","year":"2015","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2016.08.034_bib0225","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jad.2012.09.008","article-title":"Unaltered histaminergic system in depression: a postmortem study","volume":"146","author":"Shan","year":"2013","journal-title":"J. Affect. Disord."},{"issue":"2\u20133","key":"10.1016\/j.phrs.2016.08.034_bib0230","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.schres.2004.05.020","article-title":"Globus pallidus volume is related to symptom severity in neuroleptic naive patients with schizophrenia","volume":"73","author":"Spinks","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.phrs.2016.08.034_bib0235","doi-asserted-by":"crossref","first-page":"e692","DOI":"10.1038\/tp.2015.195","article-title":"Association between genetic risk scoring for schizophrenia and bipolar disorder with regional subcortical volumes","volume":"5","author":"Caseras","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.phrs.2016.08.034_bib0240","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1476-5381.2009.00149.x","article-title":"Altered histamine H3 receptor radioligand binding in post-mortem brain samples from subjects with psychiatric diseases","volume":"157","author":"Jin","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.08.034_bib0245","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-4328(01)00379-5","article-title":"Effects of histamine H3 receptor ligands GT-2331 and ciproxifan in a repeated acquisition avoidance response in the spontaneously hypertensive rat pup","volume":"131","author":"Fox","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2016.08.034_bib0250","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1124\/jpet.104.078402","volume":"313","author":"Fox","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.08.034_bib0255","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bbr.2003.11.001","article-title":"Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan","volume":"153","author":"Browman","year":"2004","journal-title":"Behav. Brain Res."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816308696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816308696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T19:50:40Z","timestamp":1536436240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816308696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":51,"alternative-id":["S1043661816308696"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.08.034","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ligand autoradiographical quantification of histamine H3 receptor in human dementia with Lewy bodies","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.08.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}